decisionhealth Newsletters, Answer Books - 2009 Issue 2 (February)
Clinical Lab Services / Advisory Opinions / OIG Advisory Opinion 99-13, November 30, 1999
Subscribe or sign in to view the full article.
Article Overview
This article summarizes an Office of Inspector General advisory opinion involving a pathology service’s proposed discounted pricing arrangement for physicians. It is relevant to compliance professionals, laboratory and pathology administrators, and coding or billing teams that monitor federal health care business arrangements and advisory guidance. The piece focuses on the OIG’s review of the proposed structure and the broader compliance considerations raised by the request.
Why This Topic Matters
Advisory opinions from the OIG can affect how laboratory and pathology organizations structure physician pricing, billing relationships, and compliance safeguards in federal health care contexts. Understanding the issue helps readers recognize the type of business arrangement reviewed and the compliance concerns involved.
What You Will Learn
- What the advisory opinion addressed at a high level
- How OIG guidance can affect laboratory and pathology business arrangements
- Why physician discount structures may be reviewed for compliance concerns
- What types of operational issues are relevant in federal health care business settings
Who Should Read This
- Compliance officers
- Pathology and laboratory administrators
- Medical billing professionals
- Healthcare counsel
- Revenue cycle teams
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com